Medtronic plc Derivative, Excluded Component, Gain (Loss), Recognized in Earnings
Medtronic plc (MDT) reported Derivative, Excluded Component, Gain (Loss), Recognized in Earnings of $50.00 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-03.
Financial Statements › Income Statement › Other Income
us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings · last filed 2026-09-03
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2026-07-31 was $50.00M, a 11.11% increase year-over-year.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2026-04-24 was $46.00M, a 8.00% decline year-over-year.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2026-01-23 was $42.00M, a 16.00% decline year-over-year.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for the quarter ending 2025-10-24 was $40.00M, a 14.89% decline year-over-year.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for fiscal 2026 was $173.00M, a 12.63% decline from fiscal 2025.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for fiscal 2025 was $198.00M, a 0.51% increase from fiscal 2024.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for fiscal 2024 was $197.00M, a 84.11% increase from fiscal 2023.
- Medtronic plc derivative, excluded component, gain (loss), recognized in earnings for fiscal 2023 was $107.00M.
| Period end | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 3 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 6 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 9 month | Derivative, Excluded Component, Gain (Loss), Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2026-07-31 | $50.00M 10-Q · filed 2026-09-03 | $96.00M derived: sum of 2 quarters · filed 2026-09-03 | $138.00M derived: sum of 3 quarters · filed 2026-09-03 | $178.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-04-24 | $46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $88.00M derived: sum of 2 quarters · filed 2026-06-18 | $128.00M derived: sum of 3 quarters · filed 2026-06-18 | $173.00M 10-K · filed 2026-06-18 |
| 2026-01-23 | $42.00M 10-Q · filed 2026-02-24 | $82.00M derived: sum of 2 quarters · filed 2026-02-24 | $127.00M 10-Q · filed 2026-02-24 | $177.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-10-24 | $40.00M 10-Q · filed 2025-11-25 | $85.00M 10-Q · filed 2025-11-25 | $135.00M derived: sum of 3 quarters · filed 2026-09-03 | $185.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-07-25 | $45.00M 10-Q · filed 2026-09-03 | $95.00M derived: sum of 2 quarters · filed 2026-09-03 | $145.00M derived: sum of 3 quarters · filed 2026-09-03 | $192.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-04-25 | $50.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $100.00M derived: sum of 2 quarters · filed 2026-06-18 | $147.00M derived: sum of 3 quarters · filed 2026-06-18 | $198.00M 10-K · filed 2026-06-18 |
| 2025-01-24 | $50.00M 10-Q · filed 2026-02-24 | $97.00M derived: sum of 2 quarters · filed 2026-02-24 | $148.00M 10-Q · filed 2026-02-24 | $196.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-10-25 | $47.00M 10-Q · filed 2025-11-25 | $98.00M 10-Q · filed 2025-11-25 | $146.00M derived: sum of 3 quarters · filed 2026-06-18 | $195.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-07-26 | $50.00M 10-Q · filed 2025-08-26 | $99.00M derived: sum of 2 quarters · filed 2026-06-18 | $148.00M derived: sum of 3 quarters · filed 2026-06-18 | $198.00M derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-04-26 | $49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $98.00M derived: sum of 2 quarters · filed 2026-06-18 | $148.00M derived: sum of 3 quarters · filed 2026-06-18 | $197.00M 10-K · filed 2026-06-18 |
| 2024-01-26 | $49.00M 10-Q · filed 2025-02-25 | $99.00M derived: sum of 2 quarters · filed 2025-02-25 | $148.00M 10-Q · filed 2025-02-25 | $181.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-10-27 | $50.00M 10-Q · filed 2024-11-26 | $99.00M 10-Q · filed 2024-11-26 | $132.00M derived: sum of 3 quarters · filed 2025-06-20 | $158.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-07-28 | $49.00M 10-Q · filed 2024-08-27 | $82.00M derived: sum of 2 quarters · filed 2025-06-20 | $108.00M derived: sum of 3 quarters · filed 2025-06-20 | $135.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-04-28 | $33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $59.00M derived: sum of 2 quarters · filed 2025-06-20 | $86.00M derived: sum of 3 quarters · filed 2025-06-20 | $107.00M 10-K · filed 2025-06-20 |
| 2023-01-27 | $26.00M 10-Q · filed 2024-02-27 | $53.00M derived: sum of 2 quarters · filed 2024-02-27 | $74.00M 10-Q · filed 2024-02-27 | |
| 2022-10-28 | $27.00M 10-Q · filed 2023-11-30 | $47.00M 10-Q · filed 2023-11-30 | ||
| 2022-07-29 | $21.00M 10-Q · filed 2023-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |